"Stenosis"

placement for asymptomatic extracranialcarotid stenosis (IPG777)© NICE 2023. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 3of 72 The condition, current treatments and procedure The condition 2.1 The main arteries in the neck (the carotid arteries) can become narrowed by fatty deposits (extracranial carotid stenosis). Blood clots can Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis Interventional procedures guidance Published: 22 November 2023 www.nice.org.uk/guidance/ipg777 Your responsibility This guidance represents the view of NICE, arrived at after careful

Tricuspid stenosis Tricuspid stenosis - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * English (US)EnglishPortuguês * Log in * Personal account * Access through your institution(Open Athens) * Subscribe * Access through your institution * Log in * English (US)EnglishPortuguês HomeSearchSearchHome * About usOverviewWhat is BMJ Best Practice?Our , you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance. OKCancelTricuspid stenosis Menu Close * Overview  * Theory  * Diagnosis  * Management  * Follow up  * Resources  * Overview * Summary * Theory * Epidemiology * Aetiology * Case history * Diagnosis * Approach * History and exam * Investigations

Endoscopic balloon dilation for subglottic or tracheal stenosis PROSPEROInternational prospective register of systematic reviews Print | PDFEffectiveness of Active Exergames for improving Cognitive Functioning in Neurological Disabilities: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsYindi Fan, Kunbin LiTo enable PROSPERO to focus on COVID-19 submissions (“OR” and “AND”), and narrowed down using the available filters on time period (from inception of database to February 2022), language (published in English language only). The detailed search strategy with search terms are (("Exergaming"[MeSH Terms] AND "Cognition"[MeSH Terms] AND "Cognitive Dysfunction"[MeSH Terms]) OR "Dementia"[MeSH Terms] OR "Parkinson Disease"[MeSH Terms] OR "Alzheimer Disease"[MeSH Terms] OR "Stroke

).Complications of pyloromyotomy include wound infection, gastric or duodenal mucosal perforation, or incomplete myotomy.DefinitionIn pyloric stenosis, hypertrophy of the pyloric sphincter results in narrowing of the pyloric canal. It is the most common cause of gastric outlet obstruction in the 2- to 12-week-old age group, and leads to progressive and projectile vomiting.[1][2][3][4]​ Pyloric stenosis may also Pyloric stenosis Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Pyloric stenosis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:10 Dec 2023Last updated:05 Jan 2024SummaryPyloric stenosis is a benign condition associated with recurrent projectile non-bilious vomiting, typically in a 2- to-12-week-old male infant.Features may

Carotid artery stenosis Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Carotid artery stenosis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:10 Dec 2023Last updated:03 Jan 2024SummaryCarotid artery stenosis is a narrowing of the lumen of the carotid artery. Approximately 10% to 15% of all ischaemic strokes are associated stenosis is less certain.DefinitionCarotid artery stenosis is a narrowing of the lumen of the carotid artery. Atherosclerotic plaque in the cervical carotid artery is the most common cause. The unique haemodynamics at the carotid bifurcation predisposes this area to atherosclerosis. The majority of patients have mild- or moderate-sized plaques, while some develop high-grade stenosis. A small percentage

valve replacement, patients are subject to the complications of prosthetic valves. DefinitionAortic stenosis (AS) is a degenerative, pathological narrowing of the aortic valve, leading to symptomatic obstruction of blood flow out of the left ventricle. It is a progressive disease that often follows aortic sclerosis (defined as aortic valve thickening without flow limitation). History and examKey Aortic stenosis Aortic stenosis - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * English (US)EnglishPortuguês中文 * Log in * Personal account * Access through your institution(Open Athens) * Subscribe * Access through your institution * Log in * English (US)EnglishPortuguês中文 HomeSearchSearchHome * About usOverviewWhat is BMJ Best Practice?Our historyKey

* Criteria * Management * Approach * Treatment algorithm * Emerging * Prevention * Follow up * Monitoring * Complications * Prognosis * Resources * Guidelines * Images and videos * References * Patient information Log in or subscribe to access all of BMJ Best PracticeLast reviewed: 7 Sep 2024Last updated: 01 Oct 2024SummaryMitral stenosis is a narrowing of the mitral valve orifice. Fusion progresses, pulmonary hypertension and right heart failure occur. Mild disease can be treated symptomatically with diuretics. Moderate to severe disease requires mechanical correction of the valve obstruction by valvotomy, valve repair, or valve replacement. DefinitionMitral stenosis is a narrowing of the mitral valve orifice, often caused by rheumatic valvulitis producing fusion of the valve commissures

Coronary sinus narrowing device implantation for refractory angina Coronary sinus narrowing device implantation for refractory angina Interventional procedures guidance Published: 24 November 2021 www.nice.org.uk/guidance/ipg712 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Evidence on the safety of coronary sinus narrowing device implantation for © NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 1 of5refractory angina shows well-recognised

Pulmonary stenosis Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languagePulmonary stenosis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:27 Aug 2023Last updated:22 Sep 2023SummaryPulmonary stenosis is mostly congenital.Symptoms range from none to profound cyanosis and the potential for sudden death.Systolic ejection murmur is present and is loudest over left upper sternal border.Cyanotic patients are treated with oxygen and prostaglandin E1 prior to diagnostic testing.The diagnosis is confirmed and severity classified by echocardiography.Mild pulmonary stenosis is a benign condition requiring sequential cardiac follow-up but no therapy.Percutaneous balloon pulmonary valvuloplasty

......................................................................................................................... 53 References ............................................................................................................................................. 57 Appendix 1: Abbreviations ..................................................................................................................... 63 SHTG Recommendations | 10 Definitions Aortic stenosis: narrowing of the aortic heart valve should provide access to a range of valves, so that the most clinically appropriate valve is available for everyone with aortic stenosis.’28 The finalised draft of the NICE late stage assessment is expected to be published in 2025. Epidemiology Aortic stenosis People with severe aortic stenosis are likely to develop symptoms associated with narrowing of the aortic valve and the overload of the heart’s

Transcatheter aortic valve implantation for patients with symptomatic severe native aortic stenosis Driving Better Decision-Making in Healthcare Page 1 TraWhen a Transcatheter aortic valve implantation for patients with symptomatic severe native aortic stenosis Technology Guidance from the MOH Medical Technology Advisory Committee Guidance Recommendations The Ministry of Health’s Medical Technology Advisory Committee has recommended transcatheter aortic valve implantation (TAVI) for symptomatic severe native aortic stenosis (AS) in line with the following criteria: ✓ TAVI may be considered for patients with symptomatic severe native AS who are inoperable or have an unacceptably high risk of mortality from surgical aortic valve replacement (SAVR) surgery and significant comorbidities

Paclitaxel-assisted balloon angioplasty of venous stenosis in haemodialysis access: PAVE RCT Paclitaxel-assisted balloon angioplasty of venous stenosis in haemodialysis access: PAVE RCT * Text only * * Home * Journals * * Other NIHR research * * For authors * For reviewers * About * * Accessibility * Journals LibraryNHS NIHR - National Institute for Health Research Select EME HSDR HTA PGfAR

Wingspan stent system for intracranial atherosclerotic stenosis Published: 15 January 2024 Driving Better Decision-Making in Healthcare Page 1 When a Wingspan Stent System for intracranial atherosclerotic stenosis Technology Guidance from the MOH Medical Technology Advisory Committee Guidance Recommendations The Ministry of Health’s Medical Technology Advisory Committee has not recommended the Wingspan stent system for intracranial atherosclerotic stenosis. Funding status The Wingspan stent system is not recommended for subsidy in patients with the abovementioned indications. Technology Guidance Driving Better Decision-Making in Healthcare Page 2 Factors considered to inform the recommendations Technology evaluation 1.1. The MOH Medical

(MR) perfusion or • MR imaging for stress-induced wall motion abnormalities. 2.5 If the results of non-invasive functional imaging are inconclusive, invasive coronary angiography is recommended. Invasive coronary angiography shows whether the arteries are blocked or narrowed, and the degree of stenosis. It is usually used as a third-line investigation for stable angina or during the initial stages QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography Diagnostics guidance Published: 17 March 2021 www.nice.org.uk/guidance/dg43 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk

Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performance Skip to main contentCreating a new NHS England: NHS Digital and NHS England have now merged. Health Education England will join us in April 2023. Learn more.Home News Publications Statistics Blogs Events Contact usSearch SearchAbout us Our work Commissioning Get involved CoronavirusTranscatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performanceDocument first published:1 February 2023Page updated:2 February 2023Topic:Heart disease, Specialised commissioningPublication type:Policy or strategyNHS England (NHSE) has

Narrow v regular diameter dental implants for mandibular overdentures MenuNO BIAS. NO MISINFORMATION. NO SPIN. JUST WHAT YOU NEED!The Dental ElfHomeAboutCategoriesPodcastsSearchHome » Posts » Dentistry » restorative dentistry »Narrow v regular diameter dental implants for mandibular overdenturesNo Responses »AUG252023Posted byDerek RichardsDental implants are now in common use and a wide variety of implant designs are available varying in diameter, length and taper. Mandibular overdentures are considered to offer advantages over conventional dentures. Narrow-diameter implants ≤3.5 mm in diameter minimise the need for alveolar bone augmentation for some patients but may have mechanical and biological limitation in comparisons with regular diameter implants (>3.5–4.5 mm in diameter).The aim

Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis Skip to Main ContentLog inDIFFUSE LUNG DISEASE: GUIDELINES AND CONSENSUS STATEMENTS| VOLUME 163, ISSUE 3, P599-609, MARCH 2023Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive BronchiolitisA Modified Delphi StudyMichael J. Falvo, PhD Anays M. Sotolongo , MDJohn J. Osterholzer, MDVasiliy V. Polosukhin, MDPaul D. Blanc, MDJeanine M. D’Armiento, MD, PhDShow all authorsOpen AccessPublished:November 04, 2022DOI:https://doi.org/10.1016/j.chest.2022.10.031PlumX MetricsBackgroundThe diagnosis of constrictive bronchiolitis (CB) in previously deployed individuals, and evaluation of respiratory symptoms more broadly, presents considerable challenges, including

Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups Get alerts of updates about «Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups»How often would you like to receive alerts from fhi.no? (This affects all

Hypertrophic Pyloric Stenosis Care Pathway This is a CONTROLLED document for internal use only. Any documents appearing in paper form are not controlled and should be checked against the electronic SharePoint version prior to use. Document Scope: Departmental Document Type: Clinical Practice Guideline Approved on 2021-09-14 Next Review Date: 2023-09-14 Hypertrophic Pyloric Stenosis Care Pathway Population:  This pathway is for use with children aged 2-8 weeks old with no underlying disease or comorbidity who have been diagnosed with hypertrophic pyloric stenosis by the General Surgery Team who require open or laparoscopic pyloromyotomy.  Patients are to be removed from this pathway if there are significant postoperative complications for example bowel obstruction or prolonged TPN

with or without low grade spondylolisthesis. The spinal canal is the channel in each vertebral bone (bones of the spine) through which the spinal cord runs. Spinal canal stenosis is the narrowing of the spinal canal, which can put Public Summary Document 2 Consumer summary pressure on the spinal cord or the nerves that go from the spinal cord to the muscles. It is a common condition, mostly occurring of the following: • neurogenic intermittent claudication secondary to a diagnosis of moderate degenerative lumbar spinal stenosis*, with or without grade 1 spondylolisthesis (on a scale of 1 to 48), confirmed by x-ray, magnetic resonance imaging (MRI) and/or computed tomography (CT) evidence of thickened ligamentum flavum, narrowed lateral recess and/or central canal or foraminal narrowing. • impaired physical